Why brand teams miss commercial growth (and what the data reveals)
In atopic dermatitis, 23% of new patient starts come from HCPs that brand teams either deprioritize...
In atopic dermatitis, 23% of new patient starts come from HCPs that brand teams either deprioritize...
We put the newest HealthVerity eXOs capabilities to the test on one of the most-watched questions...
Know what closed payer claims can reveal about patient journeys, treatment persistence and the...
Most teams planning a total cost of care or burden of illness study assume the cost data will be...
Know what others can’t about scaling AI Artificial intelligence is already embedded in how life...
Stress-testing a research question Every technology vendor claims their product works. The question...
The social determinants of health (SDoH) are a key component of understanding and delivering better...
Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system (CNS)...
Launching a pharmaceutical marketing campaign takes months of planning, creative development and...
Healthcare data now accounts for approximately 30% of global data volume and with this surge in...
In atopic dermatitis, 23% of new patient starts come from HCPs that brand teams either deprioritize or don’t have in their data at all. One in three top-decile prescribers in that same market saw zero new patient starts over a 22-month stretch. In ob...